884 F.3d 1205
D.C. Cir.2018Background
- Orton Motor (a Minnesota retailer) sold cigarettes to a minor on July 10, 2013; FDA issued a Warning Letter documenting two regulation violations (sale to minor; failure to verify ID).
- On May 16, 2015, FDA observed the same two violations at Orton; the Center charged Orton with three violations within 24 months and assessed a $500 civil money penalty under the penalty schedule.
- FDA policy (CMP Guidance and FAQs) counts only one regulation violation from a retailer’s first inspection but counts each discrete regulation violation on subsequent inspections.
- Orton argued the TCA precluded charging multiple violations from a single inspection/transaction and that FDA must provide a pre-warning-letter process to challenge a first violation.
- ALJ ruled for Orton (treated each inspection as a single violation); Departmental Appeals Board reversed, reinstating the $500 penalty; Orton petitioned for review in the D.C. Circuit.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether TCA precludes charging multiple violations from a single inspection/transaction | Orton: statute/regulatory scheme bars counting multiple violations from one inspection/transaction; first inspection should count only one violation | FDA: statute and regulations permit penalizing each separate regulatory violation; guidance policy is a permissible interpretation | Court held FDA’s interpretation persuasive under Skidmore; multiple violations may be charged when multiple regulations are breached |
| Whether FDA must provide a process to challenge a first violation before issuing a Warning Letter | Orton: TCA and due process require a pre-warning adjudicative process because first-violation notice can later increase penalties | FDA: TCA requires hearings only for assessment of civil money penalties (first violation carries $0 penalty) and warning letters have no immediate legal consequence; retailers can contest first violations when penalties are later assessed | Court held no pre-warning hearing required; warning letter suffices as notice and later adjudication provides meaningful opportunity to challenge |
Key Cases Cited
- Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010) (describing FDA’s authority under the TCA)
- Food & Drug Admin. v. Brown & Williamson Tobacco Corp., 529 U.S. 120 (2000) (limits on FDA authority under the FDCA prior to TCA)
- United States v. Mead Corp., 533 U.S. 218 (2001) (administrative deference framework)
- Christensen v. Harris Cty., 529 U.S. 576 (2000) (agency policy statements entitled to Skidmore respect, not Chevron deference)
- Skidmore v. Swift & Co., 323 U.S. 134 (1944) (factors for persuasive weight of agency interpretations)
- Holistic Candlers & Consumers Ass’n v. FDA, 664 F.3d 940 (D.C. Cir. 2012) (warning letters without legal consequences are not judicially reviewable)
- Decker v. Northwest Envtl. Def. Ctr., 568 U.S. 597 (2013) (regulations must be consistent with authorizing statute)
- Fed. Express Corp. v. Holowecki, 552 U.S. 389 (2008) (consistency of agency interpretation counts in Skidmore analysis)